PI3K inhibitor treatment ameliorates the glucocorticoid insensitivity of PBMCs in severe asthma

Jing Bi(Fudan University), Zhi Hong Chen(Fudan University)

Clinical and Translational Medicine

January 1, 2020

10.1186/s40169-020-0262-5

Cited by 38

Related Papers

Airway microbiota is associated with the severity of non‐CF bronchiectasis

|The Clinical Respiratory Journal|2020|26

Xuebijing alleviates LPS-induced acute lung injury by downregulating pro-inflammatory cytokine production and inhibiting gasdermin-E-mediated pyroptosis of alveolar epithelial cells

|Chinese Journal of Natural Medicines|2023|24